Schizophrenia and anteroventral thalamic nucleus: selective decrease of parvalbumin-immunoreactive thalamocortical projection neurons

Psychiatry Res. 1998 Apr 10;82(1):1-10. doi: 10.1016/s0925-4927(97)00071-1.

Abstract

This study was designed to examine possible anatomical changes of thalamocortical circuits in schizophrenics. Previous immunocytochemical studies have shown that parvalbumin, a calcium-binding protein, occurs in thalamocortical projection neurons, but not in GABAergic interneurons in the anteroventral thalamic nucleus (AN). Using parvalbumin-immunocytochemistry we investigated the densities of thalamocortical projection neurons in the AN of schizophrenic cases (n = 12) and controls (n = 14). The densities of all neurons in the AN were estimated by Nissl-staining. The majority of thalamocortical projection neurons in AN were identified by parvalbumin-immunoreaction. Significantly reduced densities of thalamocortical projection neurons were estimated in the right (P = 0.003) and left AN (P = 0.018) in schizophrenic subjects. The densities of all neurons in right and left AN were also diminished in schizophrenics; however, these decreases did not reach statistical significance. The reductions of parvalbumin-positive thalamocortical projection neurons were not correlated with the length of disease, this finding supporting the neurodevelopmental etiology of structural abnormalities in schizophrenia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Analysis of Variance
  • Autopsy
  • Case-Control Studies
  • Cell Count
  • Cerebral Cortex
  • Female
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Neural Pathways / pathology
  • Neurons / chemistry
  • Neurons / pathology
  • Parvalbumins / analysis
  • Schizophrenia / pathology*
  • Thalamic Nuclei / chemistry
  • Thalamic Nuclei / pathology*

Substances

  • Parvalbumins